The Testosterone Myth Men Have Been Lied To About | GLS #215

Key wellness strategies / takeaways (testosterone, prostate cancer, and “muscle-first” care)

1) Question mainstream testosterone dogma

The episode argues that common medical messaging is often misleading, including:

• “Testosterone causes prostate cancer” is described as outdated and overly simplistic fear.
• “Blocking testosterone is safe” is framed as potentially harmful and incomplete.
• Reliance on a single static “normal” lab range is criticized because it doesn’t account for:
  • aging
  • health status
  • individual biology

2) Look beyond labs: symptoms + context matter

Low testosterone should be diagnosed using the combination of:

• Low total testosterone + symptoms/signs

It also warns that “normal range” alone can miss true functional deficiency, especially when someone feels worse despite “acceptable” labs.

3) Age-specific and individualized reference thinking

The show highlights research suggesting testosterone can decline with age, supporting the idea of age-specific reference intervals. It also emphasizes that declines may be driven more by comorbidities than by aging alone.

4) Address endocrine disruptors (EDCs) as a root cause pathway

The episode repeatedly frames environmental exposures as a major contributor to hormone dysfunction—even for people who:

• “eat right”
• train hard

How EDCs may reduce testosterone (mechanisms described)

• Mimic or block hormonal signals (interfere via receptor “locking” effects)
• Anti-androgen activity (testosterone can’t work even if labs look fine)
• Increase testosterone breakdown/clearance (faster elimination)
• Brain disruption (hypothalamus/pituitary signaling interference)
• Oxidative stress in Leydig cells (reduced testosterone production)

Common exposure examples mentioned

• BPA (plastics; lining of metal food cans)
• Phthalates (personal care products; fragrances/lotions/shampoos)
• Pesticides/herbicides (e.g., atrazine; organophosphates; DDT)
• PFAS (“forever chemicals” in nonstick cookware; food packaging; water-resistant clothing)
• Parabens (preservatives in cosmetics/skin care)
• Thermal/receipt-related claims (receipts and alcohol sanitizer increasing absorption)
• Sweating/training + PFAS mention (heat/sweating as a possible route of exposure)

Practical exposure-reduction steps recommended

• Filter your water (certified filter to reduce contaminants)
• Choose safer packaging:
  • Swap plastic containers/bottles for glass or stainless steel
  • Never microwave food in plastic; transfer to glass
• Review personal care products:
  • Prefer fragrance-free
  • Prefer paraben-free
• Food approach:
  • Wash produce thoroughly or choose organic when possible

5) Reframe prostate cancer risk: “androgen saturation” concept

The episode argues prostate androgen receptors become saturated at relatively low testosterone levels (commonly cited around ~250 ng/dL). The claim: raising testosterone above that may not meaningfully “fuel” prostate cancer.

Evidence example highlighted

• A retrospective analysis of men on active surveillance who started testosterone replacement:
  • median testosterone increased substantially
  • no significant worsening in PSA progression was reported

6) Beware the risk of androgen deprivation on the brain

The show cites findings that androgen deprivation therapy (ADT) is associated with:

• increased risk of dementia/Alzheimer’s
• increased risk of Parkinson’s
• increased risk of depression

Overall message: androgens are framed as important for neurocognitive health and brain function.

7) Genetics: testosterone may not work equally for everyone (“CAG repeats”)

A core theme is no one-size-fits-all approach: androgen receptor efficiency can vary due to genetic differences (CAG repeat length). Two people can share a similar testosterone lab value but have different outcomes based on receptor responsiveness.

Symptoms that may occur even with “normal” testosterone

• low energy/fatigue
• reduced muscle mass
• less body/facial hair
• mood or sexual function changes

Action suggested

• If tested before, share CAG repeat length with your clinician (or consider discussing it) to tailor treatment decisions.

8) Actionable clinical protocols (how-to, as stated in the episode)

Step 1: Diagnostic cutoff

AUA guidance mentioned:

• total testosterone < 300 ng/dL as a reasonable diagnostic cutoff (not universal; varies by association/country)

Step 2: Proper testing protocol

Don’t rely on one casual test. Diagnose low testosterone only after:

• two separate total testosterone measurements
• on separate occasions
• early morning
• fasted

Step 3: Symptoms matter (not just numbers)

Testosterone deficiency requires:

• low total testosterone plus symptoms/signs

Step 4: Treatment targets + monitoring

The show emphasizes aiming for outcomes (symptom resolution), not only chasing a lab number. Monitoring mentioned includes:

• blood work
• lipids
• considering blood donation when appropriate (clinician-guided)

9) Muscle-centric self-care: resistance training + protein

A major “wellness/productivity” takeaway: optimize the body systems that support hormone signaling and long-term function.

Core training/nutrition recommendations

• Resistance training is non-negotiable
  • framed as helping “sensitize androgen receptors”
• Prioritize adequate protein intake
  • to support muscle protein synthesis
• Hormone optimization should be paired with muscle-building behaviors

---

Presenters or sources (as mentioned)

• Dr. Gabrielle Lyon (host/presenter)
• Dr. Mohak Gera (expert referenced)
• Dr. Abe Morgentaler (prominent urologist referenced)
• Dr. Lisa Hunt (referenced as the speaker’s doctor)
• David Goggins (mentioned in closing)
• AUA (American Urological Association) (guideline source referenced)
• Baylor College of Medicine (research teams referenced)
• Huggins and Hodges (1941 study origin referenced)
• “my husband at al” / husband referenced (research described; not named in subtitles)